TECX Tectonic Therapeutic, Inc. Common Stock Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
17:25
Mar 29
A May MD Biotech investor
The author questions the clinical efficacy and dose-response data of Merck's sotatercept, suggesting potential overvaluation.
TECX
11:31
Feb 10
A May MD Biotech investor
Short TECX as AZN's pipeline removal of their relaxin mAb signals class-level concern or validation failure, which the author reads as a direct negative catalyst for TECX's relaxin program.
TECX 1ST
HIGH

About TECX Analyst Coverage

Buzzberg tracks TECX (Tectonic Therapeutic, Inc. Common Stock) across 1 sources. 0 bullish vs 1 bearish calls from 1 analysts. Sentiment: mixed to bearish. 2 total trade ideas tracked. Latest voices: A May MD.